Owlstone wins funding for IPF lung disease breathalyser test
Bringing new products to market in the era of outsourced clinical trials is reliant on the ability of sponsors and CROs to work together.
Patients could miss out on effective treatments
Novartis says it will scale up the use of Apple ResearchKit in clinical trials, as part of its efforts to bring about digital transformation.
Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
Janssen’s UK pricing chief Jennifer Lee has called for reform of NICE following the company’s successful but drawn-out attempt to get its cancer drug Darzalex to NHS patients.
French pharma makes move into haemophilia market.